Key takeaways
- The published human study described here measured naturally occurring MOTS-c in 10 men; it did not administer MOTS-c.
- The Reynolds et al. (2021) participants were sedentary, healthy young men, with a mean age of 24.5 years.
- Registered trial NCT07505745 lists ages 18 to 65 and excludes people who are “pregnant, breastfeeding, or planning pregnancy during the study period”: a study criterion, not evidence about pregnancy.
- These records are not evidence about women, pregnancy, older adults or athletes: no published study gave MOTS-c to anyone in those groups.
01What does this page answer?
If you searched “mots-c benefits for women”, this page answers a narrower question the records can answer: who was in the human research on MOTS-c, and whom a registered trial would exclude. It does not describe effects of MOTS-c in anyone.
The page keeps three kinds of record apart: a published study’s actual participants, a registered trial’s eligibility rules, and the questions neither can answer. A registry’s exclusions describe its enrollment rules; they are not findings about people who did not enroll.
02Which human populations are described?
We separate the published human study measuring naturally occurring MOTS-c from the registered study listing eligibility for a study of MOTS-c. These are different kinds of records, so their participant numbers should not be added together as if they were one study.
| Source | Population and sex | Age and selection | What the record describes |
|---|---|---|---|
| Reynolds et al., 2021 Published human study | 10 sedentary, healthy young men. The human group described in this paper did not include women. | Mean age 24.5 years (standard deviation 3.7). Described as sedentary, with under 4 hours of aerobic exercise a week, and healthy, taking no medication or supplements. | Researchers measured naturally occurring MOTS-c in muscle and blood around exercise. They did not administer MOTS-c to the participants. |
| ClinicalTrials.gov NCT07505745 Registered study | All sexes eligible. The record lists eligibility, not enrolled participants, and has no posted results. | Ages 18 to 65; healthy volunteers not accepted. Among the listed exclusions: “Pregnant, breastfeeding, or planning pregnancy during the study period.” | The age range and exclusions are study-specific enrollment criteria. They do not report a result in any of those groups. |
The Reynolds paper describes its human group as sedentary, with an exercise-activity criterion, and as “free of cardiovascular, metabolic and blood diseases”. It does not describe an athlete cohort or state a sport-specific exclusion, so it does not show that athletes were excluded.
Likewise, the registered trial’s age range is an enrollment rule for that trial. It is not a finding about any age group.
03How should the study and registry exclusions be read?
A study’s eligibility criteria tell you who the investigators planned to enroll. They do not, by themselves, establish what would happen to people who were excluded. In this case, the registry’s pregnancy, breastfeeding, and planned-pregnancy exclusions are eligibility criteria—not findings about outcomes during pregnancy or breastfeeding.
Age is study-specific
The registry lists ages 18–65 for its study. Reynolds et al. describes a young adult group with a mean age of 24.5 years. Neither number is a finding about any age group.
Sex and activity limit the published sample
The Reynolds human group comprised men described as sedentary. The sample cannot answer whether its measurements apply to women or trained athletes.
Three checks when reading a population claim.
Reynolds et al. measured naturally occurring MOTS-c; that is different from a study that gives MOTS-c.
Note the reported sex, age, health description and activity level before applying a study’s description to anyone else.
A registry’s eligibility rules are not trial results, and a registered trial supplies no results until they are posted.
The FDA briefing document also reports that its literature search did not identify clinical studies evaluating MOTS-c administration to people. That is consistent with the distinction on this page: human measurements of naturally occurring MOTS-c are not the same as human administration studies.
For the wider research context, read the MOTS-c guide. If your question is about what a laboratory report states, see how to read a COA.
04What can’t these populations tell us?
The records described here leave important population questions unanswered. The Reynolds paper gives a small, male-only, sedentary human group. The registered trial lists a broader adult age range, excludes pregnancy and breastfeeding, and has posted no results.
They are not evidence about women, pregnancy or breastfeeding, people outside the registered age range, or athletes, and they do not show a difference by sex or age.
- Published human measurement: the body’s own MOTS-c, measured in the Reynolds study’s 10 participants.
- Registered eligibility: who could enroll in NCT07505745, and examples of exclusions.
- Results after giving MOTS-c to people: none in the published records we found (21 November 2026).
This page summarizes public study and registry records checked on 21 November 2026. It distinguishes the body’s own levels from administration and is not medical advice.